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SUMMARY
A point mutation in the cDNA of human intestinal sucrase- 
isomaltase has been recently identified in phenotype II of 
congenital sucrase-isomaltase deficiency. The mutation 
results in a substitution of glutamine by proline at position 
1098 (Q1098P) in the sucrase subunit. Expression of this 
mutant sucrase-isomaltase cDNA in COS-1 cells results in 
an accumulation of sucrase-isomaltase in the ER, interme­
diate compartment and the ds-Golgi cisternae similar to 
the accumulation in phenotype II intestinal cells. An inter­
esting feature of the QI098P substitution is its location in 
a region of the sucrase subunit that shares striking simi­
larities with the isomaltase subunit and other functionally 
related enzymes, such as human lysosomal acid a-glucosi- 
dase and Schwanniomyces occidentalis glucoamylase. We 
speculated that the Q~»P substitution in these highly 
conserved regions may result in a comparable accumula­
tion. Here we examined this hypothesis using lysosomal a- 
glucosidase as a reporter gene. Mutagenesis of the 
glutamine residue at position 244 in the homologous region 
of a-glucosidase to proline results in a protein that is 
neither transported to the lysosomes nor secreted extracel- 
Iularly but accumulates in the ER, intermediate compart­
ment and m-Golgi as a mannose-rich polypeptide similar 
to mutant sucrase-isomaltase in phenotype II.
We propose that the Q1098P and Q244P mutations 
(in sucrase-isomaltase and a-glucosidase, respectively) 
generate structural alterations that are recognized by a 
control mechanism, operating beyond the ER in the inter­
mediate compartment or m-GoIgi.
Key words: ERGIC, Intestine, Trafficking, Quality control, SI 
deficiency
INTRODUCTION
Transport of proteins along the secretory pathway is a compli­
cated multistep process involving numerous checkpoints that 
define the ultimate Tate of a newly synthesized protein. During 
recent years our understanding of the molecular events that are 
implicated in and that control the trafficking of secretory and 
membrane proteins from one cellular organelle to the other has 
evolved greatly (Rothman and Orci, 1992; Hong and Tang, 
1993; Pelham and Munro, 1993; Rothman and Wieiancl, 1996).
For instance proteins destined for the cell surface or for 
secretion into the exterior milieu are extensively modified in 
the ER before their further transport to the Golgi (for reviews 
see Pfeffer and Rothman, 1987; Doms et al., 1993). The 
chemical structure of these proteins as well as their conforma­
tion become altered after they have been synthesized and 
translocated across the ER membrane (Gething et al., 1989). 
The transport-competent conformation that proteins acquire 
prior to their transport from the ER to the Golgi and beyond is 
generally dependent on the attainment of a correct folding and
assembly into a proper quaternary structure (Pelham, 1989). 
The observed variations in the transport rates of proteins from 
the ER to the Golgi are presumably linked to different kinetics 
of protein folding and oligomerization, for example, via 
chaperon-mediated events (Hurtley and Helenius, 1989; 
Gething and Sambrook, 1992; Tatu et a l ,  1995). Consequently, 
the ER-to~Golgi transport could be considered as being rate 
limiting along the secretory pathway. Nevertheless, conforma­
tional maturation in the Golgi (Jascur et al., 1991; Matter and 
Hauri, 1991), for instance due to carbohydrate modification 
(Naim and Lentze, 1992), or oligomerization (Jascur et al., 
1991; Losch et al., 1996), may also affect the transport rates 
from the Golgi to the cell surface. This suggests that a rate- 
limiting step also exists ¿it the level of the Golgi and may at 
least in part be responsible for the asynchronous intracellular 
transport of brush border enzymes (Hauri et al., 1985; Naim et 
al., 1988b,c; Stieger et al., 1988; Naim and Lentze, 1992). In 
general, proteins leaving the ER are subjected to a ‘quality 
control’ mechanism that is responsible for sorting correctly 
folded from conformationally immature proteins, whereby
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misfolded proteins are retained and properly folded molecules 
leave the ER and traverse the Golgi on the way to their final 
destinations (Hurtley and Helenius, 1989; Hammond et al., 
1994; Ou et al., 1993).
Several observations suggest that not all proteins conform to 
this general scheme. Firstly, in congenital sucrase-isomaltase 
deficiency (CSID) two naturally occurring mutants of sucrase- 
isomaltase (SI) reveal folding patterns different from wild-type 
SI, while both are able to leave the ER (Naim et al., 1988a; 
Fransen et al., 1991). In one case, the mutant SI undergoes 
intracellular arrest as an unprocessed mannose-rich precursor 
in the medial and trans-Golgi (Naim et ah, 1988a), and the 
other phenotype is sorted to the basolateral, rather than the 
apical membrane (Fransen et al., 1991). Secondly, several 
chimeric mutants of the hemagglutinin glycoprotein, which 
persist as monomers in contrast to the trimeric wild-type 
molecule, reveal different folding patterns, and yet are able to 
egress the ER, in many cases with wild-type kinetics 
(Lazarovits and Roth, 1988). Finally, a temperature sensitive 
mutant of the vesicular stomatitis virus (VSY) glycoprotein (G 
protein) has been shown to recycle as a malfolded species 
between the ER, the intermediate compartment and the Golgi 
(Hammond and Helenius, 1994).
These findings raise questions as to whether 'minimal 
folding requirements’ exist, which should be fulfilled by 
secretory and membrane proteins before egress from the ER is 
tolerated. Additionally, there could exist a quality control 
mechanism acting beyond the ER. Studies on the transport of 
mutant glycoproteins could give insight into these questions*
We set out to investigate the molecular characteristics and 
the fate of a naturally occurring mutant form of sucrase-iso­
maltase in which the substitution Q1098P causes arrest of SI 
in the c/,v-Golgi and intermediate compartment. The same Q~>P 
mutation was introduced by site-directed mutagenesis into the 
structurally homologous lysosomal a-glucosidase at position 
244 in the evolutionary conserved region. Expression studies 
demonstrate that the Q-+P mutation in both proteins has a 
similar effect. The structural alteration resulting from this 
mutation seems to be either recognized by a quality control 
mechanism operating beyond the ER or to have altered the 
recognition site for the hypothetical ‘transport receptors’ as 
described by Rothman and Wieland (1996). Both scenarios 
result in a retention of the proteins in the intermediate com­
partment or m-Golgi, where they are finally degraded.
Table 1. Oligonucleotides used in site-directed mutagenesis 
of lysosomal a-glucosidase
MATERIALS AND METHODS
Cell lines
Monkey kidney COS cells (ATCC CRL-1650) were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
10% FCS and antibiotics. Caco~2 cells (ATCC HTB-37) were cultured 
in DMEM supplemented with 20% heat inactivated FCS, 1% non- 
essential amino acids and antibiotics (all from Gibco BRL Life Tech­
nologies GmbH, Eggenstein, Germany). All cell lines were cultured 
at 37QC in a humidified 5% CO2 incubator.
Antibodies
Four epitope-specific monoclonal antibodies directed against sucrase, 
isomaltase or sucrase-isomaltase were used (Hauri et al., 1985). These 
antibodies were products of the following hybridomas: HBB 1/691, 
HBB 2/614, HBB 2/219, HBB 3/705. Anti-ER-Golgi intermediate
Oligo
Glu 1 
G!u2 
Glu3 
Glu 4
bp (Hoefsloot et al„ 1988) Sequence S'—>3'
217-234 (coding)
960-940 (non-coding; T950G) 
937-957 (coding; A9S0C) 
1239-1222 (non-coding)
ACCATGGGAGTGAGGCAC
CTGAAGGAACGGATCCGCAAA
TTCTTTGCGGATCCGTTCCTT
GTAGAC ATC C AGGATC C C
compartment mAb ERGIC-53 was a product of hybridoma G1/93 
(Schweizer et al., 1988). Antibodies against human acid a-glucosi- 
dase comprised a product of hybridoma 43D1 (Hilkens et al,, 1981) 
and a rabbit polyclonal antiserum which was generously provided by 
Dr A. J. Reuser (Reuser et al., 1985). Polyclonal anti-protein disul­
phide isomerase (PDI, Freedman et al., 1989) was kindly provided by 
DrN. J. Bulleid, Manchester, UK, and polyclonal anti-SI was kindly 
provided by Dr A. Zweibaum, INSERM U178, Paris, France.
cDNA probes
Full length wild-type and Q1098P mutant SI cDNAs (Ouwendijk et 
al., 1996) were subcloned into the mammalian expression vectors 
pCB7 (derived from pCB6; Brewer and Roth, 1991; Gritz and Davies, 
1983) and PSG5 (Green et al., 1988). Wiid-type a-glucosidase cDNA 
was cloned into the pSG5 expression vector as described before 
(Hoefsloot et al., 1990) to generate pSHAG2.
A mutation A/C at nucleotide 950 (Hoefsloot et al., 1988) of a-glu- 
cosidase generates a substitution of glutamine by a proline at amino 
acid residue 244. This substitution corresponds with the one found at 
position 1,098 in mutant sucrase-isomaltasc.
Mutagenesis of the a-glucosidase cDNA was performed by PCR. 
Here, the primer Glu2 directed against the non-coding strand was 
designed to contain the A/C mutation at nucleotide 950 (see Table I). 
This primer together with Glu 1 in the 5'-3' direction (Table 1) were 
used to amplify a 743 bp fragment (denoted a-Glu I) (nucleotides 217 
to 960). Another pair of primers, Glu3 in the 5/-3/ direction and Glu4 
for the complementary strand (see Table 1) were used to amplify a 
302 bp DNA fragment encompassing nucleotides 937 to 1,239 
(denoted a-Glu II). Glu3 contained also the A/C mutation at 
nucleotide 950. For cloning purposes another mutation was introduced 
at position 948. This C/T mutation is silent but creates an additional 
5fl/;/HI-site. The DNA fragments a-Glu 1 and a-Glu II contained 18 
overlapping bp between nucleotides 940 and 957. These two 
fragments were assembled by assembly PCR using the primers Glul 
and Glu4 to produce a 1,022 bp DNA fragment (nucleotides 217 to
1,239). This PCR product was digested with Sacl/Stul to generate a 
348 bp fragment. This fragment replaced the Sacl-StuI fragment in 
the wild-type a-glucosidase cDNA. Sequence analysis of the 348 bp 
exchanged fragment demonstrated that only the mutations A950C and 
C948T were present (not shown). Sequencing was performed with a 
DNA sequencing kit according to the manufacturer’s instructions 
(Sequenase 2.0, United States Biochemical Corporation, Cleveland, 
OH). No other sequence alterations were found. The mutant a-glu­
cosidase cDNA was subcloned into the pSG5 expression vector to 
generate the plasmid pSHAG2A/C which was subsequently used in 
transfection experiments.
Transfection of COS-1 cells
COS-1 cells were either transfected by the DEAE-dextran method as 
described by Naim et al. (1991 a) or via electroporation as described 
before (Ouwendijk et al., 1996).
Metabolic labeling
Caco-2 cells or transiently transfected COS-1 cells were metabolically 
labeled with 80 jitCi L-[-^S]methionine (ICN Biomedicals, Mecken- 
heim, Germany) as described by Naim et al. (I99la), After the 
labeling period, the cells were washed and stored at -70°C until use.
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Immunoprecipitation and SDS-PAGE
Metabolically-labeled Caco-2 cells or transfected COS-1 cells were 
jysed at 4°C for 1 hour in lysis buffer (25 mM Tris-HCl, pH 8.0, 50 
mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxy cholate and a 
mixture of protease inhibitors containing 1 mM PMSF, 1 |ig/ml 
pepstatin, 5 ).Lg/ml leupeptin, 80 j^g/ml soybean trypsin inhibitor and 
1 jug/ml aprotinin, all from Sigma, Deisenhofcn, Germany). Usually 
1 ml ice-cold lysis buffer was used for each 100 mm culture dish 
(about 2-4x106 cells). The mixture of protease inhibitors was omitted 
from the lysis buffer when the sensitivity of SI towards trypsin was 
assessed (see later). Detergent extracts of cells were centrifuged for 1 
hour at 100,000 g at 4°C and the supernatants were immunoprecipi­
tated as described by Naim et al. (1991 a). For epitope mapping studies 
with four epitope-specilic monoclonal antibodies directed against 
sue rase, isomaltase or sucrase-isomaltase the extracts of Caco-2 cells 
or transfected COS-1 cells were divided into equal aliquots and each 
aliquot was iinmunoprecipitated with a different antibody. Usually, 
0.2 \.i\ mAb in the form of ascites was used for each immunoprecip- 
ilation. Human a-glucosidase was iinmunoprecipitated using 0,5 p.1 
of a rabbit polyclonal anti-human a-glucosidase serum (Reuser et al., 
1985).
SDS-PAGE was performed according to the method of Laemmli 
(1970) and the apparent molecular masses were assessed by compar­
ison with high molecular mass markers (Bio-Rad Laboratories GmbH, 
Miinchen, Germany) run on the same gel. in some experiments, de- 
glycosylation of the immunoprecipitates with Endo-N-acetylglu- 
cosaminidasc H (Endo H), Endo-N-aeetylglucosaminidase F/gly- 
copeptidase F (Endo F/GF, also known as PNGase F) (both from New 
England Biolabs GmbH, Schwalbach/Taunus, Germany) was 
performed prior to SDS-PAGE analysis as described before (Naim et 
al., 1987).
Trypsin treatments
Metabolically labeled cells were solubilized in lysis buffer without 
protease inhibitors and subsequently treated with trypsin (500 fig/ml, 
Sigma, Dejsenhofen, Germany) for various time periods or with 
various trypsin concentrations for 30 minutes ¿it 37°C. The reaction 
was stopped by cooling on ice and the addition of soybean trypsin 
inhibitor (Sigma, Deisenhofen, Germany) and protease inhibitors.
Enzyme activities
Disitccharida.se activities were measured according to the method of 
Dahlqvisl (1968), using sucrose and isomaltose as substrates. Protein 
quantities were determined by western blotting and densitometric 
scanning of lluorograms.
Immunofluorescence
Cellular localization of expressed proteins in COS-1 cells was studied 
with cells grown on coverslips. Cells were lixed with 3% 
paraformaldehyde and permeabilized with 0.1% Triton X-100. 
Immunolabeling was carried out using niAb anti-SI (HBB1/614), 
mAb anii-ERGIC-53, polyclonal anti-SI, polyclonal anti~PDI, mAb 
anti-a-glucosidase (43DJ) and polyclonal anti-human a-glucosidase 
as the primary antibodies. The secondary antibodies employed FITC- 
conjugated goat anti-mouse or swine anti-rabbit IgG* Texas Red-con- 
jugated goat anti-mouse or anti-rabbit IgG (all were from Boehringer 
Mannheim BV, Almere, the Netherlands). Surface localization of 
proteins was assessed in transfected cells that were not fixed nor per­
meabilized; labeling was carried out at4°C. Label was visualized with 
a Bio-Rad MRC1000 confocal scanning laser microscope using a 
double channel for fluorescein isothiocyanate and Texas Red or on a 
routine fluorescence microscope.
Immuno electron microscopy
Ultrastructural localization studies were performed on transfected 
COS-1 cells, Cells were fixed with 1% paraformaldehyde (PFA) and 
0-1% glutaraldehyde in phosphate buffer (pH 7.3) for 1 hour, scraped
and spun down in 10% gelatin. Pellets were fixed and stored until use 
in 1% PFA. Ultrathin cryosectioning was performed as described 
before (Schweizer et al., 1988; Fransen et al., 1985). Sections were 
incubated with mAbs against SI (HBB 2/614/88) or a-glucosidase 
(43D1), followed by a rabbit polyclonal serum against mouse IgG 
(Dako A/S, Glostrup, Denmark) and Protein A complexed with 10 nm 
gold (Fransen et al., 1985). Electron microscopy was performed with 
a JEOL 1010 electron microscope.
RESULTS
Human sucrase-isomaltase expressed in COS-1 
cells reveals similar structural and biosynthetic 
features as the naturally expressed enzyme in 
intestinal cells
Wild-type SI produced in transfected COS-1 cells is indis­
tinguishable in its behavior on SDS-PAGE from the SI 
naturally produced in intestinal epithelial cells (Ouwendijk et 
al., 1996). Furthermore, the wild-type enzyme expressed in 
COS-1  cells was processed with the same rate as in intesti­
nal cells and showed comparable enzymatic activities (not 
shown) and glycosylation patterns: the 245 kDa complex gly­
cosylated form appears after approximately the same times of 
chase (Fig. 1). It can therefore be assumed that the folding 
pattern of the wild-type SI expressed in COS-1 cells is 
normal.
The enzyme expressed in COS-1 cells was further investi­
gated with respect to trypsin sensitivity, an indicator for protein 
folding. For this purpose Caco-2 cells and transfected COS-1 
cells were biosynthetically labeled for 5 hours and the 
detergent extracts were treated with trypsin. Under these con­
ditions the mannose-rich SI precursor (pro-SI) as well as the 
complex glycosylated form become accessible to the protease. 
Cell lysis without protease inhibitors did not result in pro­
teolytic cleavage of pro-SI (Fig. 2, lane 2 and 7). Likewise both 
cell types behaved similarly when trypsin was added to the 
lysates. The pattern obtained with trypsin in both cell types is 
comparable and was maintained at 500 ¡ag of trypsin for at least
3 hours (Fig. 2, lanes 5 and 11). The observed differences in 
the intensity of the proteins derived from Caco-2 and trans­
fected COS-1 cells (compare lanes 1-5 with 6-11) are most
Chase (hr.) 0 1 2.5 5.5
COS-1
Caco-2
0m <■
mm
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kDa
245
210
245
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Fig. 1. Processing of SI in COS-1 and Caco-2 cells. Caco-2 and 
transfected COS-1 cells were biosynthetically labeled with 
[35S]methionine for 1.5 hours, and chased for the indicated times. 
Homogenates of these specimens were immunoprecipitated with 
monoclonal anti-SI antibodies. Immunoprecipitates were subjected to 
SDS-PAGE on 5% slab gels. Gels were analyzed by fluorography.
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Fig. 2. Trypsin sensitivity of SI in Caco-2 cells and COS-1 cells. 
Caco-2 and transfected COS-1 cells were biosynthetically labeled 
with [35S]methionine for 5 hours. The specimens were homogenized, 
solubilized and treated with 500 ¡ag/ml trypsin for the indicated 
times. After the reaction was stopped with protease inhibitors the 
samples were immunoprecipitated with monoclonal anti-SI 
antibodies. The immunoprecipitates were subjected to SDS-PAGE on 
5% slab gels. Gels were analyzed by fiuorography.
likely due to differences in the labeling efficiency of the two 
cell types.
Since differently folded molecules are expected to behave 
differently towards the same protease, in this case trypsin, the 
results lend strong support to the notion that the folding of pro- 
SI in Caco-2 cells and COS-1 cells is similar.
To corroborate these data by another approach, we probed 
the folding of pro-SI with epitope-specific monoclonal anti­
bodies. These mAbs recognize specific conformations or 
different epitopes of SI (Hauri et ah, 1985). Therefore, the 
binding of these antibodies to pro-SI in COS-1 cells would be 
consistent with the notion that the corresponding epitopes on 
pro-SI in COS-1 cells and in intestinal cells display compara­
ble folding patterns. All antibodies reacted with pro-SI from 
both cell types and with comparable affinities (not shown). 
Since the epitopes recognized by these antibodies are randomly 
distributed over the pro-SI molecule, it is reasonable to assume 
that the overall folding pattern of pro-SI in both cell types is 
comparable or similar.
Altogether, the protease sensitivity measurements and the 
epitope mappings with four monoclonal antibodies indicate 
that no gross structural differences exist between pro-SI in 
COS-1 and Caco-2 cells.
Analysis of the folding pattern of mutant human 
sucrase-isomaltase expressed in COS-1 cells
The mutation Q1098P elicits similar effects on the posttrans- 
lalional processing of SI in transfected COS-1 cells as in 
intestinal epithelial cells (Ouwendijk et aL, 1996), In both cell 
types the mutant protein is not complex glycosylated, but accu­
mulates as a high-mannose precursor in the ER, intermediate 
compartment and the cis-Golgi. We investigated the biosyn­
thesis of mutant SI in transfected COS-1 cells by pulse-chase 
analysis. As shown in Fig. 3, mutant SI persists as a high-
Chase (hr.) 0 | 1 12 .515.5
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Fig. 3. Processing of wild-type (Wt) and mutant (Q1098P) SI in 
COS -1 cells. Cells were biosynthetically labeled with 
[35S]methionine for 1.5 hours, and chased for the indicated times. 
Homogenates of these specimens were immunoprecipitated with 
monoclonal anti-SI antibodies. Immunoprecipitates were subjected to 
SDS-PAGE on 5% slab gels. Gels were analyzed by fiuorography.
mannose polypeptide during its entire life cycle. The intensity 
of this form becomes weaker with increasing chase periods 
indicating that the protein undergoes intracellular degradation, 
most likely in the ER. Degradation in the lysosomes could be 
excluded, since the mutant SI protein is not tranported beyond 
the ER, ERGIC and the cis-G olgi (see later Figs 7 and 8).
To investigate whether the mutant enzyme would acquire 
additional trypsin sensitive sites when expressed in COS-1 
cells the experiments described in Fig. 2 were repeated with 
transfected COS-1 cells expressing wild-type or mutant SI. Fig.
4 shows that neither mutant pro-SI nor the anticipated sucrase 
or isomaltase subunits were visible after lysis of the cells 
without protease inhibitors (Fig. 4,2nd lane) indicating that the 
mutant pro-SI underwent complete degradation after exposure 
to endogenous proteases. Wild-type SI was processed correctly 
within 30 minutes of trypsin treatment (Fig. 4, ‘Wt’). The high- 
mannose as well as the complex-glycosylated species of
s i Q 1 0 9 8 P W t
pfotease Inh, + - +
T rypsln fig/ml 0 0 20 100 500 0 0 20 100)600
■  8 8 1 8
^  n
ProSlc 
ProSI ^
I c
Sc
<Lhsh
Fig. 4. Trypsin sensitivity of mutant Q1098P and wild-type (Wt) SI. 
Transfected COS-1 cells were biosynthetically labeled with 
[35S] methionine for 5 hours. The specimens were homogenized, 
solubilized and treated for 30 minutes at 37°C with the indicated
j
trypsin concentrations. After the reaction was stopped with protease 
inhibitors the samples were immunoprecipitated with monoclonal 
anti-SI antibodies. The immunoprecipitates were subjected to SDS- 
PAGE on 5% slab gels. Gels were analyzed by fiuorography. In these 
experiments, mutant SI transfected cells were less efficiently labeled 
(compare 1st lane ‘Q1098P’ with 1st lane ‘Wt*). Sc, Ie, proSIc: 
complex glycosylated sucrase subunit, isomaltase subunit, proSI 
(resp.); Sh, Ih, proSIh: high mannose sucrase subunit, isomaltase 
subunit, proSI (resp.).
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cells. However, double labeling was already established by 
confocal laser scanning microscopy.
Collectively (a) the double-labeling experiments show co­
localization with ERGIC-53; (b) the protein is not complex 
glycosylated, which excludes the possibility that it has reached 
the trans-Colgi; and (c) the EM-localization demonstrate that 
the Q.1098P mutation has induced in a rion-epithelial heterol­
ogous transfection system a similar phenotype of SI as that 
identified in the biopsy sample.
Analysis of mutant lysosomal acid a-glucosidase 
expressed in COS-1 cells
To investigate the influence of the Q1098P mutation in a 
different protein the Q at position 244 in a-glucosidase was 
mutated to P. COS-1 cells were transfected with wild-type and 
Q244P a-glucosidase cDNA and labeled for 3 hours. The 
detergent extracts and the culture medium were immunopre­
cipitated with anti-a-glucosidase antibodies and subjected to 
SDS-PAGE with or without Endo H and Endo F/GF treatments. 
As shown in Fig. 9, wild-type a-glucosidase appeared as a 
polypeptide of Mv 110,000 (lane 1) consistent with previous 
reports (Wisselaar et al., 1993; Reuser et a l, 1985, 1987). 
Treatment of this polypeptide with Endo H revealed a broad
band of Mr 95,000-105,000 (Fig. 9, lane 2). This pattern was 
not due to incomplete digestion of the mannose-rich chains, 
since higher concentrations of Endo H did not affect it (not 
shown). The diffuse pattern of the Endo H product indicates 
that the Mf 110,000 species comprises Endo H-sensitive as well 
as Endo H-resistant or partially Endo H-resistant carbohydrate 
side chains as has been also observed in Caco-2 cells 
(Klumperman et al., 1991). In fact, Endo F/GF, which cleaves 
mannose-rich as well as complex type N-l inked oligosaccha­
rides, shifted the Mr 110,000 species to a Mv 95,000 band (Fig. 
9, lane 3). This result therefore indicates that a-glucosidase 
arrived in the Golgi, where it acquired complex type of 
glycans. By contrast, the mutant Mv 110,000 a-glucosidase 
species persisted completely as a mannose-rich polypeptide, 
since both Endo H and Endo F/GF generated a similar 
digestion product of Mr 95,000 (Fig. 9, lanes 4-6). Further­
more, wild-type lysosomal a-glucosidase was partially 
secreted by COS-1 cells (Fig. 9, lanes 7-9) consistent with 
previous reports (Hoefsloot et al., 1990), Mutant a-glucosi­
dase, however, was not discerned in the culture medium (Fig.
9, lanes 10-12). Altogether, the results clearly demonstrate that 
the mutant a-glucosidase has neither been processed in the 
Golgi apparatus nor secreted into the culture medium.
It is known that lysosomal a-glucosidase undergoes phos­
phorylation in the c/s-Golgi at some of its mannose-residues 
and is then transported to the lysosomes via binding to the 
mannose 6 -phosphate receptor. On its way to, and in the 
lysosomes proteolytic processing to a M v 95,000 intermediate 
and finally to the Mx 76,000 enzymatically mature protein 
occurs (Wisselaar et a l ,  1993; Reuser et al., 1985, 1987).
To determine whether mutant a~glucosidii.se reaches the 
lysosomes and undergoes cleavage, transfeciad COS-1 cells 
were metabolically labeled for 1.5 hours and chased for the 
indicated time periods (Fig. 10)* As a control mock-trans- 
fected COS-1 cells underwent the same procedure. Fig. 10 
demonstrates that the wild-type protein was intracellularly 
processed into the Mr 95,000 intermediate and to the Mr
76.000 protein (‘cells', upper panel). These two bands were 
partially sensitive to Endo H treatment, while treatment with 
Endo F/GF resulted in a further shift of the two species, com­
parable to the digestion pattern of wild-type a-glucosidase in 
Fig. 9, lane 1-3 (not shown). The Endo H sensitivity indicates 
that some mannose-rich chains have not been processed in the 
Golgi to complex glycosylated glycans. This is mainly due to 
phosphorylated mannose residues of the carbohydrate chains, 
which do not undergo further processing in the Golgi 
apparatus and are required for correct sorting of a-glucosi­
dase to the lysosomes (Wisselaar et al., 1993; Reuser et al., 
1985, 1987).
A proportion of the M r 1 10,000 precursor, but neither the Mx
95.000 nor the Mr 76,000 processed forms were secreted by 
COS-1 cells expressing wild-type a-glucosidase (Fig. 10, 
‘medium1, upper panel). The faint bands in the control ( ‘Cells1, 
lower panel) are a result of a weak reaction of endogenous a -
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Fig. 9. Glycosylation of mutant Q244P and wild-type (Wt) a- 
glucosidase. Transfected COS-1 cells were biosynthetically labeled 
with [35S] methionine for 1.5 hours. The cells were homogenized and 
solubilized. Homogenates and medium were immimopreeipitated 
with polyclonal anti-a-glucosidase antibodies. The 
immunoprecipitates were treated with Endo H (lanes 2, 5, 8, 11), 
Endo F/GF (lanes 3, 6, 9, 12) or left untreated (lanes 1,4, 7, 10).
They were subjected to SDS-PAGE on 7% slab gels. Gels were 
analyzed by fluorography.
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Fig. 10. Processing of mutant Q244P and wild-type (Wt) a -  
glucosidase. COS-1 cells were transfected with cDNA coding for 
mutant Q244P a-glucosidase, wild-type a-glucosidase (Wt) or 
mock-transfected (control). The cells were biosynthetically labeled 
with [35S]methionine for 1.5 hours, chased for the indicated times, 
homogenized and solubilized. Homoge nates and medium were 
immimopreeipitated with polyclonal anti-a-glucosidase antibodies, 
Immunoprecipitates were subjected to SDS-PAGE on 7% slab gels. 
Gels were analyzed by fluorography.
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glucosidase with the antibodies. Mutant Q244P a-glucosidase 
persisted as a high-mannose precursor polypeptide, was not 
processed to its mature form as the wild-type molecule and was 
not secreted into the medium (Fig. 10, middle panels). The 
results indicate that mutant a-glucosidase is neither transported 
to the cell surface nor to the lysosomes.
Altogether, the results demonstrate that wild-type a-glu­
cosidase is transport-competent since it has been processed in 
the Golgi, sorted to the lysosomes and partially secreted into 
the medium (Hoefsloot et al., 1990), By contrast, the mutant 
a-glucosidase protein persisted as a Mx 1 1 0 ,000, mannose-rich 
polypeptide and was not processed to the Mr 95,000 or Mr
76,000 forms (Fig. 10, 'cells’, middle panel). Furthermore, no 
secreted Mv 110,000 precursor forms could be detected even 
after a chase period of 20 hours (Fig. 10, middle panel, 
‘medium1) and longer exposure of the gel (not shown). 
Together, mutant a-glucosidase is a transport-incompetent 
molecule that persists as a mannose-rich precursor and is 
finally degraded, most likely in the ER.
Subcellular localization of wild-type and mutant 
lysosomal a-glucosidase expressed in COS-1 cells
Having assessed the biosynthetic features of mutant a-glu­
cosidase we wanted to determine its subcellular localization 
and see whether the mutation Q244P has also induced a similar 
transport block as that observed with mutant SI. Fig* 6C shows 
a punctate staining pattern typical of the lysosomes as well as 
ER and Golgi staining in COS-1 cells expressing wild-type a- 
glucosidase. The punctate pattern was completely absent in 
cells expressing mutant a-glucosidase, and instead immuno­
fluorescence images corresponding predominantly to ER struc­
tures were observed (D).
Double-labeling experiments of mutant a-glucosidase with 
PDI and ERGIC-53 (Fig. 7E and F) resulted in co-localization 
of mutant a-glucosidase with PDI (E), and ERGIC-53 (F) in 
regions around the nucleus.
Immuno EM analysis of wild-type a-glucosidase expressed 
in COS-1 cells revealed labeling in the ER, in the lysosomes 
and at the cell surface (Hoefsloot et al., 1990). Non-transfected 
cells were devoid of label (not shown). Mutant Q244P a-glu­
cosidase, however, did not show label in the lysosomes nor at 
the cell surface (not shown), but was localized in the ER and 
in vesicles and cisternae at one side of the Golgi apparatus (Fig. 
8B), comparable to mutant Q1098P SI (Fig. 8A).
The results indicate that the mutation Q244P in a-glucosi­
dase has produced a similar phenotype as Q1098P in SI, which 
is characterized by a block in the transport at the level of 
ERGIC and cis-Golgi. It is therefore concluded that this highly 
conserved region of the molecules is important for the correct 
processing and transport of both enzymes.
DISCUSSION
Analysis of congenital sucrase-isomaltase deficiencies has 
resulted in the identification of different phenotypes showing 
transport incompetence of the SI protein. In a recent paper we 
analyzed the cDNA of a phenotype II patient and found a point 
mutation which generates a Q1098P substitution responsible 
for a block of the molecule in the ER-Golgi intermediate com­
partment and the cis-Golgi (Ouwendijk et al., 1996). From
these studies the question arose about the possible existence of 
a quality control mechanism operating at a level beyond the
ER.
Here we analyze the Q1098P substitution in more detail and 
demonstrate that it is not only functional in intestinal epi­
thelial cells but also produces a similar phenotype when 
expressed in non-polarized COS-1 cells. This supports the view 
that (i) the Q1098P mutation per se is responsible for the gen­
eration of the SI phenotype; and (ii) cellular factors specific for 
epithelial cells are not implicated in the onset of this CS1D 
phenotype.
The expression of a similar CSID phenotype in COS-1 cells 
using the patients cDNA enabled us to analyze the processing 
of the mutant SI protein. One important observation was the 
folding state of the mutant SI protein. Here protease sensitiv­
ity assays using trypsin demonstrate that the mutant SI is not 
as stable as its wild-type counterpart and is degraded within a 
relatively short period of time. Interestingly, the sucrase as well 
as the isomaltase subunits are degraded. While a ma'lfolded 
sucrase subunit as a result of the mutation Q1098P is expected
to exploit a different pattern of trypsin sensitivity as compared 
to wild-type sucrase, the concomitant degradation of isomal- 
tase can be explained as follows.
Wild-type SI does not have its protease resistent conforma­
tion directly after translation. It reaches this conformation after 
a certain ‘lag-period’ during which both subunits are suscepti­
ble to degradation (Matter and Hauri, 1991). Probably mutant 
SI cannot reach this conformation because; (a) The protein is 
not transported into the compartment with the proper ‘folding 
machinery’; (b) the mutation makes it energetically impossible 
to attain the proper folding; or (c) because of the improper 
folding of sucrase the SI-protein is not transported further, so 
isomaltase is not folded properly either and remains protease 
sensitive as well.
Alternatively, associations between the sucrase and isomal­
tase subunits could mask putative trypsin cleavage sites in 
either subunit preventing further cleavage. One type of associ­
ation could take place after the independent folding of each 
subunit. These are ultimately assembled as pseudodimers 
(Jascur et al., 1991) which efficiently leave the ER. Another 
type of association could take place very early in the ER, where 
the subunits possibly assist each other to fold properly and in 
this way function as ‘intramolecular chaperons’ (Oberholzer et 
al., 1993; Sagherian et al., 1994; Naim et a l, 1994). In mutant 
SI, these protective associations might be absent, resulting in 
exposed protease sensitive sites.
Another interesting feature of the Q1098P mutation is its 
presence in a region that shares striking homologies between 
human, rat and rabbit sucrase and isomaltase variants as well 
as human lysosomal a-glucosidase and Schw. occidentalis glu- 
coamylase (Fig. 1 1 ) (Naim et al., 1991b). These proteins, 
which have been suggested to have evolved from a common 
ancestral gene, are all synthesized and translocated into the ER 
where they are processed to transport-competent forms and 
then transported along the secretory pathway to their final des­
tinations. SI is sorted, most likely in the TGN, to the apical 
membrane. Lysosomal a-glucosidase is after phosphorylation 
in the cis-Golgi and maturation in the medial and trans-Golgi 
mainly transported to the lysosomes, but is also to a lesser 
extent secreted at the apical membrane in polarized epithelial 
cells. Schw: occidentalis glucoamylase is transported to the
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Fig. 11. Partial alignment of the amino acid .sequences of human 
sucrase (Chantret et alM 1992), mutant sucrase (Ouwendijk et al, 
1996), human isomaltase (Chantret et al., 1992), human a- 
glucosidase (Hoefsloot et al., 1988) and mutant a-glucosidase. The 
box indicates a homologous region around the Q1098P mutation. 
The numbering above the sequences is the sucrase amino acid 
numbering, below the sequences is the a-glucosidase numbering. 
Both mutations are typed in boldface.
periplasmic space and partially secreted into the exterior milieu 
in yeast. Obviously all three proteins share a common pathway 
from the ER to the Golgi and from there diverge to different 
destinations, it is therefore conceivable that homologies in the 
polypeptide sequences should be implicated in common 
functions needed for proper transport or catalytic activity. If 
the mutation Q1098P does not induce gross conformational 
changes in the sucrase subunit, but rather alters a subdomain 
that is critical for the intracellular transport of SI, then a similar 
effect might be expected if the same mutation is introduced into 
the corresponding homologous regions of lysosomal a-glu- 
cosidase or Schw. occidentalis glucoamylase.
Our results show indeed that the Q1098P mutation of 
sucrase elicits a similar effect when introduced at the corre­
sponding amino acid position 244 in lysosomal a-glucosidase. 
The mutated lysosomal a-glucosidase precursor as well as the 
mutant SI precursor remain mannose-rich polypeptides that do 
not undergo maturation in the Golgi, are not cleaved into 
mature enzyme and are not transported through the Golgi 
cisternae. It is conceivable that the homologous domain of a- 
glucosidase, sucrase and isomaltase harbor a structural motive 
with a potential role in transport signaling or quality control 
acting at the level of ERGIC-m-Golgi at which level the 
mutant proteins are blocked. The observations described here 
can be explained as follows: ( 1 ) the mutation has introduced a 
retention signal for the d.v-Golgi; (2) the mutation has lead to 
the recognition of the protein by the ER-Golgi recycling 
machinery; or (3) the mutation has lead to a structural alter- 
ation that functions as a recognition site for a quality control 
machinery operating in the intermediate compartment or cis- 
Golgi,
The lirst possibility suggests that a single point mutation 
alters a highly conserved region into a region with a novel 
function. Although it cannot be excluded, we think this is very 
unlikely.
The second possibility is that mutant SI and lysosomal a~ 
glucosidase exit the ER, are transported to ERGIC or m-Golgi 
and then are recycled back to the ER. Recent observations with 
a temperature sensitive mutant of the VSV G protein have 
shown that at the non permissive temperature the G protein 
leaves the ER, arrives in the ERGIC and the m-Golgi and 
recycles back to the ER. Presumably several cycles of ER- 
ERGIC-ER occur during which the G protein is always found 
associated with the luminal binding protein (BiP) and calnexin 
in the ER and with BiP in ERGIC (Hammond and Helenius,
1994). In view of these findings the hypothesis has emerged 
that misfolded proteins that have escaped the ER are retrieved 
from ERGIC or cis-Golgi back to the ER presumably to be 
reexposed to the folding machinery and thus have additional 
opportunities to acquire correct folding. A similar recycling 
mechanism between the ER and ERGIC or ¿/¿’-Golgi is poten­
tially possible for mutant SI and lysosomal a-glucosidase. In 
the case of the VSV G protein a retrieval mechanism to the ER 
has been proposed that implicates the binding of the BiP/VSV 
G complex to the BiP receptor in the ER. Although we do not 
know whether SI or lysosomal a-glucosidase bind BiP or 
calnexin, a retrieval mechanism of mutant SI or lysosomal a - 
glucosidase complexes with ER-resident proteins cannot be 
excluded.
The third possibility is that a quality control mechanism 
operates at a level beyond the ER and prevents misfolded 
proteins from being further transported along the secretory 
pathway to the cell surface. After longer periods ihe mutant 
proteins are finally degraded, We suggest therefore that the 
QI098P mutation in SI and the Q244P mutation in a -g lu ­
cosidase have generated structural alterations in the proteins 
that cause an arrest by a control mechanism operating in the 
intermediate compartment or e/s-Golgi. A comparable 
situation has been reported for misfolded major histocom­
patibility complex (MHC) class I molecules in mice that are 
deficient for TAPI, the transporter associated with antigen 
presentation (Raposo et al., 1995). In these mice the MHC 
molecules cannot bind to peptides, which prevent the 
complexes from folding properly. As a result they accumu­
late in an expanded ER-Golgi intermediate compartment. 
Although we did not find exactly the same expansion, we did 
report an enlargement of the Golgi complex and a change in 
the localization of ERGIC-53 in the patient’s intestinal cells 
(Ouwendijk et al., 1996).
In essence, the analysis of CSID has resulted in the identi­
fication of a mutation that is responsible for a block of the 
molecule in the ERGIC or the m -G olgi. Although our results 
favor a possible quality control mechanism in these compart­
ments, analysis of the binding kinetics of mutant SI and 
lysosomal a-glucosidase with BiP or calnexin is required to 
determine whether a recycling mechanism is possible for these 
proteins- The observations regarding the role of a highly 
conserved region of SI in proper transport of the molecule 
could be an interesting contribution to the identification of 
novel control steps involved in proper transport along the 
secretory pathway.
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